Complex cytotoxicity mechanism of bundles formed from self-organised 1-D anodic TiO


Journal

Journal of hazardous materials
ISSN: 1873-3336
Titre abrégé: J Hazard Mater
Pays: Netherlands
ID NLM: 9422688

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 02 10 2019
revised: 23 12 2019
accepted: 07 01 2020
pubmed: 19 1 2020
medline: 31 12 2020
entrez: 19 1 2020
Statut: ppublish

Résumé

The present study reports on a comprehensive investigation of mechanisms of in vitro cytotoxicity of high aspect ratio (HAR) bundles formed from anodic TiO

Identifiants

pubmed: 31954312
pii: S0304-3894(20)30040-6
doi: 10.1016/j.jhazmat.2020.122054
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
titanium dioxide 15FIX9V2JP
Titanium D1JT611TNE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

122054

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Hana Michalkova (H)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia.

Zuzana Skubalova (Z)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia.

Hanna Sopha (H)

Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia; Center of Materials and Nanotechnologies, Faculty of Chemical Technology, University of Pardubice, Nam. Cs. Legii 565, CZ-530 02 Pardubice, Czechia.

Vladislav Strmiska (V)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia.

Barbora Tesarova (B)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia.

Simona Dostalova (S)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia.

Pavel Svec (P)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia.

Ludek Hromadko (L)

Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia; Center of Materials and Nanotechnologies, Faculty of Chemical Technology, University of Pardubice, Nam. Cs. Legii 565, CZ-530 02 Pardubice, Czechia.

Martin Motola (M)

Center of Materials and Nanotechnologies, Faculty of Chemical Technology, University of Pardubice, Nam. Cs. Legii 565, CZ-530 02 Pardubice, Czechia.

Jan M Macak (JM)

Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia; Center of Materials and Nanotechnologies, Faculty of Chemical Technology, University of Pardubice, Nam. Cs. Legii 565, CZ-530 02 Pardubice, Czechia.

Vojtech Adam (V)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia.

Zbynek Heger (Z)

Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czechia; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, CZ-612 00 Brno, Czechia. Electronic address: heger@mendelu.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH